<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="37238">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02621762</url>
  </required_header>
  <id_info>
    <org_study_id>293_15</org_study_id>
    <nct_id>NCT02621762</nct_id>
  </id_info>
  <brief_title>Pilot Study to Investigate the Effects of Increased Dialysate Magnesium and Dialysate Bicarbonate on the Calcification Propensity of Serum</brief_title>
  <acronym>BicMag</acronym>
  <official_title>Pilot Study to Investigate the Effects of Increased Dialysate Magnesium and Dialysate Bicarbonate on the Calcification Propensity of Serum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to determine the effect size of magnesium and bicarbonate supplementation as
      a basis for future randomized controlled trials aiming at the T50-guided improvement of hard
      clinical endpoints in dialysis patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of treatment on serum calcification propensity, measured by T50</measure>
    <time_frame>7 weeks</time_frame>
    <description>T50: Transformation time of primary calciprotein particles to secondary calciprotein particles (Pasch et al, 2012)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with treatment-related adverse events</measure>
    <time_frame>7 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>End Stage Renal Failure on Dialysis</condition>
  <condition>Vascular Calcification</condition>
  <arm_group>
    <arm_group_label>Mg first</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receives MgCl2 first, MgCl2 and Bicarbonate in second phase</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bicarbonate first</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receives Bicarbonate first, MgCl2 and Bicarbonate in second phase</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Magnesium</intervention_name>
    <description>Magnesium in dialysate increased</description>
    <arm_group_label>Mg first</arm_group_label>
    <arm_group_label>Bicarbonate first</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bicarbonate</intervention_name>
    <description>Bicarbonate in dialysate increased</description>
    <arm_group_label>Mg first</arm_group_label>
    <arm_group_label>Bicarbonate first</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female hemodialysis patients ≥ 18 years of age

          -  Negative pregnancy test of female patients in child-bearing age

          -  The patients have to be able to understand the character and the individual impact of
             the clinical study and they have to give written informed consent to participate in
             the study

          -  Start of chronic hemodialysis treatment ≥ 3 months ago

          -  HCO3- in venous plasma ≤23 mmol/L before the start of the last dialysis of the week

          -  Magnesium in venous plasma ≤ 1.45 mmol/L before the start of the first dialysis of
             the week

          -  T50 ≥ 200 minutes.

        Exclusion Criteria:

          -  Pregnant or lactating subjects. A blood pregnancy test will be performed at the
             screening visit in female patients of childbearing age.

          -  History of alcohol abuse, illicit drug use, significant mental illness, physical
             dependence to any opioid, or any history of drug abuse or addiction within 12 months
             of study enrolment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>111 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominik Uehlinger, Prof Dr.med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Inselspital, Berne</affiliation>
  </overall_official>
  <reference>
    <citation>Pasch A, Farese S, Gräber S, Wald J, Richtering W, Floege J, Jahnen-Dechent W. Nanoparticle-based test measures overall propensity for calcification in serum. J Am Soc Nephrol. 2012 Oct;23(10):1744-52. Epub 2012 Sep 6.</citation>
    <PMID>22956818</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 4, 2016</lastchanged_date>
  <firstreceived_date>November 26, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Calcinosis</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Vascular Calcification</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dialysis Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
